Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Questions 1/17/08

Questions 1/17/08

posted on Jan 17, 2008 11:06AM

1. What is PTSC's policy for communicating with shareholders?

The monthly letter to shareholders is long overdue.  Why?

 Why no pr with the recent 10Q?

 Are you aware of any share price manipulation, and if you are what do you attribute it to?

Shareholders would like to know that we have a voice.  Can Brian Biajj take a more active role in being our shareholder representative by allowing him to post on Agoracom updates approved through the BOD?  Also as our contact to deliver questions and concerns to the BOD and post what he can? 

Where does PTSC see itself in the next year, 2 years, 5 years?  Is PTSC on target for accomplishing it's goals of M&A, Licensing, and getting off the OTCBB?

 Question: If you are indeed under the "cone of silence" would it be possible to extend it to cover new licenses as the signing of obscure companies at a time when many are desperate for some actual guidance from management does nothing at this time but furter cripple the SP and add to the belief by many potential investors that this is going nowhere and is to be avoided. While it is currently fashionable among "true longs" to maintain a stiff upper lip and see everything that comes along as a positive there are many out there that have given up on this stock and events like today's and "rumors" of  "possible" communications sometime next week furter damage are already shakey credibility. In short, in a situation where we are looking for a sign and you throw us instead a license to a company few have ever heard of and of course give no indication of terms or fees paid which then results in a significant SP decline then IMO many here would agree that silence is indeed golden.

Share
New Message
Please login to post a reply